| Sep'18 | Sep'17 | Sep'16 | ||||
|---|---|---|---|---|---|---|
Grant income | ||||||
1,407 | 1,693 | 1,212 | ||||
Operating expenses: | ||||||
Research and development | ||||||
36,150 | 16,012 | 10,436 | ||||
General and administrative | ||||||
22,790 | 9,099 | 5,152 | ||||
Total operating expenses, net | ||||||
57,533 | 23,418 | 14,376 | ||||
Other income (expense): | ||||||
Interest income | ||||||
1,532 | 84 | 75 | ||||
Other income (expense) | ||||||
3,970 | -46 | -26 | ||||
Total other income, net | ||||||
5,502 | 38 | 49 | ||||
Net loss before income tax | ||||||
-52,031 | -23,380 | -14,327 | ||||
Income tax benefit | ||||||
-7,280 | -3,653 | -1,777 | ||||
Net loss attributable to ordinary shareholders | ||||||
-44,751 | -19,727 | -12,550 | ||||
Other comprehensive (loss) income: | ||||||
Foreign currency exchange translation adjustment | ||||||
-6,071 | 802 | -2,942 | ||||
Total comprehensive loss | ||||||
-50,822 | -18,925 | -15,492 | ||||
Basic and diluted net loss per ordinary share (usd per share) | ||||||
-1.42 | -1.43 | -1.26 | ||||
Weighted-average basic and diluted ordinary shares (shares) | ||||||
31,557 | 13,783 | 9,933 | ||||